Solutions for

Sensitive detection for efficient screening

AusDiagnostics SARS-CoV-2 assays have been shown to be highly sensitive and specific1 for the detection of SARS-CoV-2. With updated respiratory target panels, you can detect two distinct regions of the SARS-CoV-2 genome concurrently with important seasonal respiratory pathogens.

Our respiratory MT-PCR panels can detect the SARS-CoV-2 variants that have recently emerged in the UK, South Africa, and Brazil, and we are working on a panel that will allow genotyping.

  1. Attwood LO, Francis MJ, Hamblin J, Korman TM, Druce J, Graham M, Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay, Journal of Clinical Virology (2020). doi:

Prioritising your needs first

Being the first company to create a diagnostic test for SARS-CoV-2 in Australia, AusDiagnostics has created even more products to support COVID-19 testing. From sample purification to diagnostic result and automation, we have optimised our solutions to fit your specific needs. What’s more, we have dedicated manufacturing facilities to ensure that the local healthcare community can reliably access much needed reagents and kits to screen and detect SARS-CoV-2.

Automation to deliver results faster

Confidently manage the high throughput demands of rigorous testing with our robotic liquid handling platforms. With versatile options to integrate into existing laboratory setups, or to upgrade and transform configurations for maximum output, our automated extraction and diagnostics platforms make handling ever changing needs of COVID-19 testing stress-free.

Find your extraction and multiplexed PCR automation solution.